Connect with us

Technology

Cumulus Neuroscience Presents Data at AAIC 2026 Annual Meeting Showing a Two-Minute Digital Task Matches or Outperforms Clinical Benchmarks for Alzheimer’s Trial Pre-enrichment

Published

on

Across three independent studies, the NeuLogiq® Platform two-minute tablet-based Symbol Swap task delivered clinically meaningful discrimination between control, MCI and Alzheimer’s dementia groups and detected blood-biomarker-defined pathology — including in clinically normal individuals — with accuracy matching or exceeding the ADAS-Cog, MoCA and MMSE benchmarks.

LONDON, July 15, 2026 /PRNewswire/ — Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, today presented data on its Symbol Swap digital cognitive task at the Alzheimer’s Association International Conference 2026. The poster titled, ‘A Brief Digital Symbol-Coding Task Outperforms Clinical Benchmarks for Alzheimer’s Trial Pre-enrichment,’ reports interim data on Symbol Swap — a two-minute, tablet-based implementation of the classic Symbol Coding (Digit Symbol Substitution) Task that measures executive function — across one completed at-home study and two large in-clinic studies.

Across three independent studies, Symbol Swap matched or exceeded the pre-enrichment performance of established clinical cognitive screeners in just two minutes, delivering clinically meaningful discrimination between control, MCI and Alzheimer’s dementia groups while dramatically reducing participant and site burden. It showed robust associations with biomarker-defined Alzheimer’s pathology (blood plasma pTau-217), even in clinically normal individuals who would typically score well on standard tests — suggesting it could flag those most likely to be amyloid- or tau-positive and improve the efficiency of downstream plasma, PET or CSF screening. Digitally administered and automatically scored, Symbol Swap scales readily across large, multi-site trials in both in-clinic and at-home workflows, making it an attractive first-line enrichment filter — preceding plasma biomarkers or feeding composite digital endpoints — with the potential to cut screen-failure rates and accelerate recruitment into Alzheimer’s trials.

“It is striking that a two-minute, patient-friendly task can match or beat assessments that take a trained clinician 10 to 45 minutes to administer— and that it picks up Alzheimer’s pathology even in study participants who look cognitively normal on standard tests,” said Brian Murphy, PhD, Cumulus Co-Founder and CSO. “This data confirms that Symbol Swap may be a powerful first-line filter, preceding plasma biomarkers or feeding a multimodal composite. We are grateful to all the study participants and research collaborators who made these important findings possible.”

Symbol Swap was evaluated in CNS-101, a first-of-its-kind validation study that measured functional neurophysiology with the NeuLogiq Platform at home in patients living with mild Alzheimer’s dementia and healthy controls (compared with the ADAS-Cog); the Fastball i4i study (in-clinic; compared with the MoCA); and the Global Alzheimer’s Platform (GAP) BioHermes-002 study (20 sites across the US, Canada and Europe; compared with the MMSE). Pathology status in CNS-101 and the Fastball i4i study was defined by the AlzPath phosphorylated-tau 217 assay. Data presented from the Fastball i4i study and BioHermes-2 study are interim.

“The Bio-Hermes-002 study is focused on enrolling participants with or without memory concerns to help evaluate blood or digital tests that may help identify the presence of amyloid plaques or tau tangles in the brain, the hallmark pathologies associated with Alzheimer’s disease,” said Lammert Albers, Chief Commercial Officer for GAP. “The data presented by Cumulus suggests that digital assessments, including Symbol Swap, may help identify individuals who are more likely to have underlying Alzheimer’s pathology and could support more efficient selection of participants for follow-up blood-based biomarker testing. This approach has the potential to shorten enrollment timelines and lower screening costs.”

A second poster featuring NeuLogiq data titled ‘Multi-domain Digital Endpoints for Decentralized Alzheimer’s Trials: Experience from the CNS-101 Study (NeuLogiq®),’ was presented by Dr. James Rowe, Professor of Cognitive Neurology at the University of Cambridge and Principal Investigator on CNS-101. This study confirmed NeuLogiq Platform cognitive and EEG assessments were well tolerated by study participants, and their sensitivity could enable smaller, more efficient trials.

“Alzheimer’s trials have long depended on assessments that are burdensome for participants and difficult to use at scale,” said Dr. James Rowe, Professor of Cognitive Neurology at the University of Cambridge and Principal Investigator on CNS-101. “In CNS-101 we found that multi-domain digital cognitive and EEG measures from the NeuLogiq Platform were well tolerated by people living with Alzheimer’s disease and sensitive enough to capture meaningful change. That sensitivity makes it possible to design smaller, more efficient trials — reducing the burden on patients while lowering the time and cost to test new therapies.”

“Getting the right participants into trials is one of the most expensive and frustrating bottlenecks in Alzheimer’s drug development today,” said Tina Sampath, CEO of Cumulus. “A low-cost, patient-friendly, automatically scored task that runs at home or in clinic, and points to who is most likely to be biomarker-positive, has real potential to cut screen-failure rates and ease the burden on patients and sites. The two posters presented at AAIC tell a connected story: alongside Symbol Swap’s power to enrich at the front end, our CNS-101 data show that NeuLogiq’s multi-domain cognitive and EEG endpoints are well tolerated and sensitive enough to enable smaller, more efficient trials — together, that’s a path to substantially reducing the cost and timeline of every study where they’re deployed.”

Cumulus supports precision in CNS clinical trials for its industry partners by enabling remote monitoring of patients across multiple domains of brain function. To learn more, visit www.cumulusneuro.com.

About Cumulus Neuroscience

With a mission to generate the data and insights required to accelerate diagnosis and management of central nervous system (CNS) disorders for millions of patients and caregivers around the world, Cumulus Neuroscience is advancing NeuLogiq®, an AI-based, multi-domain digital biomarker platform to enable better, faster decision making in neurology and neuropsychiatry clinical trials and patient care. Designed for and with 10 of the world’s leading pharma companies, the platform enables decentralized trials and is already making a difference in the development of therapies for Alzheimer’s Disease, depression and schizophrenia.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cumulus-neuroscience-presents-data-at-aaic-2026-annual-meeting-showing-a-two-minute-digital-task-matches-or-outperforms-clinical-benchmarks-for-alzheimers-trial-pre-enrichment-302826250.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Frost & Sullivan: CrowdStrike Named Company of the Year for Identity Threat Detection and Response

Published

on

By

Continuous, risk-aware identity security becomes the market standard as AI agents and non-human identities (NHIs) expose the limitations of fragmented, static access controls

AUSTIN, Texas, July 16, 2026 /CNW/ — Frost & Sullivan is pleased to announce that CrowdStrike has been named the 2026 Global Company of the Year in Identity Threat Detection and Response (ITDR). As AI agents transform how work gets done, operating with superhuman speed and access, this recognition validates CrowdStrike’s leadership in advancing the market beyond static access controls with “a next-generation identity model that enables continuous and content-aware dynamic authorization across human, non-human, and AI agent identities.”

“Identity is the front line of modern attacks and AI is accelerating the threat at scale,” said Elia Zaitsev, chief technology officer at CrowdStrike. “AI agents operate as high-privilege identities with access to critical data, applications, compute resources, and other agents, exposing the risk of legacy access models built on static policies and standing privileges.”

Frost & Sullivan’s research has found that CrowdStrike eliminates standing privileges and enforces real-time, risk-based access that can be dynamically revoked as conditions change, establishing Falcon Next-Gen Identity Security as the identity security control plane for the agentic enterprise.”

Identity Security for the Agentic Enterprise

The Falcon® Next-Gen Identity Security business surpassed $520 million in ending ARR, growing more than 34% year-over-year.[1] CrowdStrike’s ability to secure both human and agentic identities makes Falcon Next-Gen Identity Security the standard for identity security in the agentic enterprise.

Frost & Sullivan stated, “CrowdStrike’s unified, cloud native platform that delivers end-to-end identity visibility, just in time privileges, behavioral analytics, and automated response across human and non-human identities enables a significant competitive advantage.”

Key findings from the Frost & Sullivan report include:

Securing SaaS and AI Agents

Frost & Sullivan recognized how CrowdStrike delivers “real time visibility into AI and SaaS agents, including their permissions, data access, and activity, and can monitor how these identities interact with sensitive systems and datasets over time.”

Zero Standing Privileges

Frost & Sullivan highlighted that “unlike traditional role assignments or vaulting, Falcon Next-Gen Identity Security treats every user as potentially privileged, granting only need-based, real-time behavior and context aware access.”

End-to-End Identity Security

Frost & Sullivan praised CrowdStrike’s protection across the identity lifecycle, from phishing resistant MFA to enabling customers to use “SOAR workflows to automatically reset compromised passwords, remediate risky accounts in batches, and enforce conditional access or privilege controls based on real time risk scores.”

Unified Outcomes

Frost & Sullivan recognized CrowdStrike for delivering a “unified, cloud-native platform that treats identity as a first-class security signal alongside endpoints, cloud, and data.” And noted that “the leadership team’s focus in translating megatrends into a coherent product strategy rather than a set of disjointed features is evident as the company builds a model of zero trust access for every identity.”

Additional Resources

To learn more about Frost & Sullivan’s 2026 Company of the Year for Identity Threat Detection and Response, visit here.To learn more about Falcon Next-Gen Identity Security, visit here.

About CrowdStrike
CrowdStrike (NASDAQ: CRWD), a global cybersecurity leader, has redefined modern security with the world’s most advanced cloud-native platform for protecting critical areas of enterprise risk – endpoints and cloud workloads, identity and data.

Powered by the CrowdStrike Security Cloud and world-class AI, the CrowdStrike Falcon® platform leverages real-time indicators of attack, threat intelligence, evolving adversary tradecraft and enriched telemetry from across the enterprise to deliver hyper-accurate detections, automated protection and remediation, elite threat hunting and prioritized observability of vulnerabilities.

Purpose-built in the cloud with a single lightweight-agent architecture, the Falcon platform delivers rapid and scalable deployment, superior protection and performance, reduced complexity and immediate time-to-value.

CrowdStrike: We stop breaches.

Learn more: https://www.crowdstrike.com/

Follow us: Blog | X | LinkedIn | Instagram

Start a free trial today: https://www.crowdstrike.com/trial

© 2026 CrowdStrike, Inc. All rights reserved. CrowdStrike and CrowdStrike Falcon are marks owned by CrowdStrike, Inc. and are registered in the United States and other countries. CrowdStrike owns other trademarks and service marks and may use the brands of third parties to identify their products and services.

Media Contact
Jake Schuster
CrowdStrike Corporate Communications
press@crowdstrike.com 

1 CrowdStrike Q4 FY26 Earnings

View original content:https://www.prnewswire.com/news-releases/frost–sullivan-crowdstrike-named-company-of-the-year-for-identity-threat-detection-and-response-302827671.html

SOURCE Frost & Sullivan

Continue Reading

Technology

InventHelp Inventor Develops Protective Cell Phone Case (TKA-476)

Published

on

By

PITTSBURGH, July 16, 2026 /PRNewswire/ — “I wanted to create a new phone case to help protect your phone from falling to the ground and breaking,” said an inventor, from Clarkston, Ga., “so I invented the AIR DROP. My design also offers a secure grip for one-handed operation, and it could act as a stand for easy viewing.”

The patent-pending invention provides an effective way to protect a cell phone against drops and damage. In doing so, it prevents the phone from falling to the floor, ground, water, etc. As a result, it eliminates unnecessary repairs and replacement costs. It also offers a more comfortable and convenient way to use and view a phone. The invention features a secure and comfortable design that is easy to use so it is ideal for the owners and users of cell phones. Additionally, a prototype model and technical drawings are available upon request.

The original design was submitted to the National sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 25-TKA-476, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp’s Invention Submission Services at http://www.InventHelp.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/inventhelp-inventor-develops-protective-cell-phone-case-tka-476-302827401.html

SOURCE InventHelp

Continue Reading

Technology

Archy Launches Archy Revenue to Help Dental Practices Save Time and Get Paid Faster

Published

on

By

New AI-powered capability automates insurance payment posting inside Archy, helping teams auto-post routine payments, review exceptions, and move away from paper-check workflows.

SAN JOSE, Calif., July 16, 2026 /PRNewswire/ — Archy today announced Archy Revenue, a new paid upgrade built directly into the Archy practice management platform to help dental practices automate the busy work of posting insurance payments. With Archy Revenue, a practice can bring paper and electronic insurance payments into one workflow, let AI read and match the payment to the right claim, automatically post claims paid as expected, and surface the exceptions that still need the team’s judgment.

For many dental practices, getting paid by insurance is one of the most manual parts of the business. Teams often have to search for the right claim, enter payment details line by line, reconcile deductibles and patient responsibility, and finalize each payment manually. Even when the insurance payment is correct, staff still have to review and click through work that does not need a decision. For bulk payments with dozens of claims, that process can take hours away from patient follow-up, collections, and running the practice.

Archy Revenue was built to address that work inside the system dental teams already use. When an insurance payment comes in, Archy Revenue reads the payment, matches it to claims in Archy, fills in payment details, and posts the claims that were paid as expected. Claims that need review, such as denied claims or claims with increased patient responsibility, are surfaced in an exception queue so the practice can focus on the few items that actually require attention.

Extending beyond paper payments, Archy Revenue includes a managed enrollment service for electronic insurance payments, helping offices get paid up to a week faster. As Archy completes enrollment on behalf of the office, electronic remittances are automatically retrieved and follow the same AI-powered matching, auto-posting, and exceptions experience as paper payments. One posting flow, regardless of how the payment comes in.

Archy Revenue launches with four core capabilities:

AI-powered insurance payment processing: Practices can upload up to 10 insurance payment PDFs at once for analysis. After just a few minutes, Archy Revenue reads the payment, matches claims in Archy, and fills in procedure-level deductible, patient responsibility, and insurance payment amounts. A built-in PDF viewer highlights where information was extracted, giving teams confidence in what the system found.

Auto-posting for claims paid as expected: When a claim is paid exactly as estimated, Archy Revenue posts it automatically so the team does not have to review work that does not need a decision. Practices can see a filtered view of exceptions, use auto-finalize when all claims on a payment are reconciled, and keep an audit trail for every auto-posted claim.

Managed electronic payment enrollment: Archy enrolls practices with top payers for electronic payments and remittances. Once set up, remittance information is retrieved automatically, payment information is pre-filled in Archy, and future-dated payments are held until the payment date. An auto-generated remittance PDF simplifies secondary claim filing.

One workflow for paper and electronic insurance payments: Whether a practice uploads a scanned explanation of benefits, a PDF from a payer portal, or receives an electronic remittance, the review experience is consistent. The same workflow helps teams match claims, review only what needs attention, and post payments without exports, extra logins, or reconciling between separate systems.

Archy Revenue also brings the company’s founder story back into the product. Archy was created after its founders saw how outdated, disconnected software slowed down real dental practices. For Archy co-founder and CEO Jonathan Rat, insurance payment posting became especially personal after helping his wife, dentist and practice owner, work through insurance paperwork on weekends. Archy Revenue turns that firsthand frustration into a product capability designed to give dental teams that time back.

“Insurance payment posting is personal for me because I watched it take over my Saturdays in my wife’s practice,” said Jonathan Rat, co-founder and CEO of Archy. “Dental teams already did the hard part. They took care of the patient. They should not have to lose hours chasing down the payment after that. Archy Revenue is built to give that time back, by posting what can be posted safely, surfacing what needs a decision, and helping practices get paid faster without adding another system.”

Archy Revenue is part of Archy’s broader investment in AI built directly into dental practice workflows. Alongside Archy Scribe, which helps dentists create clinical notes inside Archy, Archy Revenue applies the same platform-native approach to insurance payments. Rather than adding another disconnected tool, Archy is building AI into the core operating system of the dental practice, so teams can reduce administrative work while staying in control of the decisions that matter.

About Archy

Archy is all-in-one dental practice management software built to help dental teams run more of their practice from one connected platform. Founded by Jonathan Rat and Ben Kolin after seeing firsthand how outdated, fragmented systems slowed down real dental practices, Archy brings scheduling, clinical workflows, patient communication, insurance, billing, reporting, payments, and AI-powered tools together in one modern system. Archy helps dental professionals reduce complexity, move faster, and spend more time focused on patients and practice growth.

Andrew Bernstein – abernstein@archy.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/archy-launches-archy-revenue-to-help-dental-practices-save-time-and-get-paid-faster-302827199.html

SOURCE Archy Dental, Inc.

Continue Reading

Trending